<DOC>
	<DOCNO>NCT01628549</DOCNO>
	<brief_summary>To evaluate safety effectiveness 3 strength P005672 compare placebo treatment moderate severe facial acne .</brief_summary>
	<brief_title>Double-Blind , Placebo-Controlled Study Evaluate 3 Doses P005672 Treatment Facial Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>male female , 1245 year age body weight 52 88 kg diagnosis acne vulgaris : 20 50 inflammatory lesion ( papule , pustule , nodule ) 30 100 noninflammatory lesion ( open &amp; closed comedo ) 2 nodule face Investigator 's Global Assessment ( IGA ) score moderate ( 3 ) severe ( 4 ) dermatological condition face facial hair could interfere clinical evaluation prolong QTcF ( &gt; 450msec ) Baseline ECG pseudomembranous colitis antibioticassociated colitis hepatitis , liver damage renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>acne</keyword>
</DOC>